Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
QRX003 Lotion in Netherton Syndrome
NCT07538583Phase 3Recruiting
- Sponsor
- Quoin Pharmaceuticals Ltd.
- Start
- Mar 2026
- Primary completion
- Jan 2027
- Modality
- Transdermal Patches, Hydrogel Systems, Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of QRX003 in Netherton syndrome (NS), sponsored by Quoin Pharmaceuticals Ltd.. Started Mar 2026; status: recruiting.
02
Drugs
QRX003
03
Conditions
Netherton syndrome (NS)
Beyond the preview
Go deeper on NCT07538583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07538583.